| Literature DB >> 22726923 |
Shabbir M H Alibhai1, Sara O'Neill, Karla Fisher-Schlombs, Henriette Breunis, Joseph M Brandwein, Narhari Timilshina, George A Tomlinson, Heidi D Klepin, S Nicole Culos-Reed.
Abstract
Patients with acute myeloid leukemia (AML) receiving induction chemotherapy (IC) were enrolled in a supervised exercise intervention to determine safety, feasibility, and efficacy. Physical fitness measures, quality of life (QOL) and fatigue were assessed using standardized measures at baseline, post-induction, and post first consolidation. Retention was excellent, the intervention was safe, and efficacy estimates suggested benefits in physical fitness and QOL outcomes. Exercise is a safe, promising intervention for improving fitness and QOL in this patient population. These results provide a foundation for a randomized trial to better understand the impact of exercise during IC on clinically important outcomes.Entities:
Mesh:
Year: 2012 PMID: 22726923 PMCID: PMC3767429 DOI: 10.1016/j.leukres.2012.05.016
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156